These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 14765730)

  • 1. Systemic absorption of amitriptyline and buspirone after oral and transdermal administration to healthy cats.
    Mealey KL; Peck KE; Bennett BS; Sellon RK; Swinney GR; Melzer K; Gokhale SA; Krone TM
    J Vet Intern Med; 2004; 18(1):43-6. PubMed ID: 14765730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of transdermal methimazole in a pluronic lecithin organogel (PLO) in healthy cats.
    Hoffman SB; Yoder AR; Trepanier LA
    J Vet Pharmacol Ther; 2002 Jun; 25(3):189-93. PubMed ID: 12081614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of buspirone extended-release tablets: a single-dose study.
    Sakr A; Andheria M
    J Clin Pharmacol; 2001 Jul; 41(7):783-9. PubMed ID: 11452712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and CNS pharmacodynamics of the 5-HT1A agonist buspirone in humans following acute L-tryptophan depletion challenge.
    Jagannathan V; Venitz J
    Methods Find Exp Clin Pharmacol; 1997 Jun; 19(5):351-62. PubMed ID: 9379784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of a newly identified active metabolite of buspirone after administration of buspirone over its therapeutic dose range.
    Dockens RC; Salazar DE; Fulmor IE; Wehling M; Arnold ME; Croop R
    J Clin Pharmacol; 2006 Nov; 46(11):1308-12. PubMed ID: 17050795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of serum dexamethasone concentrations in cats after oral or transdermal administration using pluronic lecithin organogel (PLO): a pilot study.
    Willis-Goulet HS; Schmidt BA; Nicklin CF; Marsella R; Kunkle GA; Tebbett IR
    Vet Dermatol; 2003 Apr; 14(2):83-9. PubMed ID: 12662265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic study of oral amitriptyline in horses.
    Recchi L; Alvariza S; Benech A; Ruiz N; José Estradé M; Suarez G; Crosignani N
    J Vet Pharmacol Ther; 2020 Jul; 43(4):381-384. PubMed ID: 32339314
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of transdermal and oral cyclosporine in six healthy cats.
    Miller R; Schick AE; Boothe DM; Lewis TP
    J Am Anim Hosp Assoc; 2014; 50(1):36-41. PubMed ID: 24216498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Buspirone transdermal administration for menopausal syndromes, in vitro and in animal model studies.
    Shumilov M; Touitou E
    Int J Pharm; 2010 Mar; 387(1-2):26-33. PubMed ID: 19961912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An assessment of the in vivo effects of intravenous lipid emulsion on blood drug concentration and haemodynamics following oro-gastric amitriptyline overdose.
    Perichon D; Turfus S; Gerostamoulos D; Graudins A
    Clin Toxicol (Phila); 2013 May; 51(4):208-15. PubMed ID: 23530458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of buspirone following oral administration to rhesus monkeys.
    Marathe PH; Shen F; Markham P; Greene DS
    J Pharm Pharmacol; 1999 May; 51(5):601-7. PubMed ID: 10411220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of pharmacokinetic interaction between buspirone and haloperidol in patients with schizophrenia.
    Huang HF; Jann MW; Wei FC; Chang TP; Chen JS; Juang DJ; Lin SK; Lam YW; Chien CP; Chang WH
    J Clin Pharmacol; 1996 Oct; 36(10):963-9. PubMed ID: 8930784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical pharmacokinetics and pharmacodynamics of buspirone, an anxiolytic drug.
    Mahmood I; Sahajwalla C
    Clin Pharmacokinet; 1999 Apr; 36(4):277-87. PubMed ID: 10320950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amitriptyline absorption in a patient with short bowel syndrome.
    Robbins B; Reiss RA
    Am J Gastroenterol; 1999 Aug; 94(8):2302-4. PubMed ID: 10445571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative bioavailability of fluoxetine after transdermal and oral administration to healthy cats.
    Ciribassi J; Luescher A; Pasloske KS; Robertson-Plouch C; Zimmerman A; Kaloostian-Whittymore L
    Am J Vet Res; 2003 Aug; 64(8):994-8. PubMed ID: 12926591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
    Khan S; Patil K; Yeole P; Gaikwad R
    J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic characterization of OROS and immediate-release amitriptyline.
    Gupta SK; Shah JC; Hwang SS
    Br J Clin Pharmacol; 1999 Jul; 48(1):71-8. PubMed ID: 10383563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced bioavailability of buspirone from reservoir-based transdermal therapeutic system, optimization of formulation employing Box-Behnken statistical design.
    Gannu R; Palem CR; Yamsani SK; Yamsani VV; Yamsani MR
    AAPS PharmSciTech; 2010 Jun; 11(2):976-85. PubMed ID: 20517714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.